Online citations, reference lists, and bibliographies.
← Back to Search

Reverse Micelle-loaded Lipid Nanocarriers: A Novel Drug Delivery System For The Sustained Release Of Doxorubicin Hydrochloride.

S. Vrignaud, N. Anton, P. Gayet, J. Benoît, P. Saulnier
Published 2011 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In this study, we are pioneering new nanotechnology for the encapsulation of anticancer drugs (doxorubicin (DOX) and/or docetaxel (DOCE)), whatever their solubility and water affinity. The purpose of this study is to highlight the potential of this recently patented technology, by carrying out a thorough physicochemical characterisation of these multiscaled nanocarriers, followed by the study of an encapsulation and release model of hydrophilic anticancer drug. The formulation process is based on a low-energy nano-emulsification method and allows the generation of a structure composed of oil-based nanocarriers loaded with reverse micelles. Thanks to this, hydrophilic contents can be solubilised in the oily core of this kind of nano-emulsion along with lipophilic content. The results emphasise some original structure particularities due to the multistep formulation process, and the diffusion-based behaviour revealed for the DOX release profile that is shown to be intimately linked to the morphology of the particles.
This paper references
10.1016/j.ijpharm.2009.05.014
The universality of low-energy nano-emulsification.
N. Anton (2009)
10.1021/JA065462C
Self-assembled nanocages for hydrophilic guest molecules.
M. Jones (2006)
10.1023/A:1016121319668
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
10.1021/la901565q
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules.
N. Anton (2009)
10.1021/LA026339B
Incorporation and Release of Hydrophobic Probes in Biocompatible Polycaprolactone-block-poly(ethylene oxide) Micelles: Implications for Drug Delivery
P. Soo (2002)
10.1016/S1773-2247(08)50015-3
Particular conductive behaviors of emulsion phase inverting
Nicolas Anton (2008)
10.1007/s10549-008-0271-3
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
Adam J Shuhendler (2008)
10.1016/J.ELECTACTA.2008.11.018
Synthesis and functionalization of magnetic nanoparticles with covalently bound electroactive compound doxorubicin
M. Brzozowska (2009)
10.1016/J.IJPHARM.2007.03.009
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
J. Liu (2007)
10.1016/j.biomaterials.2008.12.042
Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery.
S. Guo (2009)
10.1016/S0169-409X(01)00112-0
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
J. Siepmann. (2001)
10.1002/1097-4628(20001017)78:3<517::AID-APP60>3.0.CO;2-3
DOXORUBICIN-LOADED POLY(BUTYLCYANOACRYLATE) NANOPARTICLES PRODUCED BY EMULSIFIER-FREE EMULSION POLYMERIZATION
S. C. Yang (2000)
10.1006/JCIS.2000.6810
Surface Pressure, Hysteresis, Interfacial Tension, and CMC of Four Sorbitan Monoesters at Water-Air, Water-Hexane, and Hexane-Air Interfaces.
Peltonen (2000)
10.2217/nnm.09.108
Beta-cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin delivery.
L. Y. Qiu (2010)
10.1007/s11095-004-1196-0
Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying
C. Dulieu (2004)
10.1002/JPS.20961
Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
M. Chavanpatil (2007)
10.1016/J.CAP.2006.11.031
Self-assembled nanoparticles based on linoleic-acid modified carboxymethyl-chitosan as carrier of adriamycin (ADR)
C. Liu (2007)
10.1016/J.EJPS.2006.06.003
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles.
D. Missirlis (2006)
10.1158/1535-7163.MCT-06-0289
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats
E. Garcion (2006)
10.1006/PHRS.2000.0695
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
A. Fundaró (2000)
10.1016/j.ijpharm.2010.07.039
Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials.
N. Anton (2010)
10.1080/10717540600740045
Reverse Micelle-Based Microencapsulation of Oxytetracycline Hydrochloride into Poly-d,l-Lactide-co-Glycolide Microspheres
Hyunjoo Kim (2007)
10.1039/C0SM00272K
Reverse micelles from amphiphilic branched polymers
Marie-Christine G. Jones (2010)
10.1007/978-94-009-4712-2
Synthetic membranes : science, engineering, and applications
P. Bungay (1986)
10.1021/bm800913r
Block Copolymer Micelles as Nanocontainers for Controlled Release of Proteins from Biocompatible Oil Phases
A. Miller (2009)
10.1016/j.ejpb.2010.06.007
Polymeric micelles for oral drug delivery.
G. Gaucher (2010)
10.5555/URI:PII:009377549290207H
The cardiotoxicity of chemotherapeutic drugs.
A. Allen (1992)
Analysis of Fickian and non-Fickian drug release from polymers.
N. Peppas (1985)
10.1016/S0928-0987(02)00241-5
The influence of lipid nanocapsule composition on their size distribution.
B. Heurtault (2003)
10.1016/J.CIS.2007.02.002
Reverse micelles: inert nano-reactors or physico-chemically active guides of the capped reactions.
V. Uskoković (2007)
10.1023/B:PHAM.0000016235.32639.23
Solubilizing Excipients in Oral and Injectable Formulations
R. Strickley (2004)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
10.1021/JP0664768
Salting-out effect induced by temperature cycling on a water/nonionic surfactant/oil system.
N. Anton (2007)
10.1007/s11095-006-9203-2
Surfactant-polymer Nanoparticles: A Novel Platform for Sustained and Enhanced Cellular Delivery of Water-soluble Molecules
M. Chavanpatil (2006)
10.1016/0169-409X(95)00026-4
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.
R. Gref (1995)
10.1016/j.jconrel.2008.02.007
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
10.1016/J.JCONREL.2006.05.013
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
10.1016/J.IJPHARM.2007.04.027
Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
N. Anton (2007)
10.1002/POL.1969.160070511
Diffusion in glassy polymers. III
T. T. Wang (1969)



This paper is referenced by
10.22377/AJP.V13I02.3111
In Vitro-In Vivo Characterization of Oleuropein loaded Nanostructured Lipid Carriers in the Treatment of Streptococcus pneumoniae induced Meningitis
K. B. Reddy (2019)
10.1007/s11064-020-03122-y
Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
C. Fressinaud (2020)
10.1016/j.colsurfb.2015.03.014
Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin.
N. Nafee (2015)
10.1016/j.jlumin.2019.116816
The photophysics of a hydrophilic molecule in the presence of graphene oxide
Aloke Bapli (2020)
10.1186/s11671-016-1755-4
pH-Responsive Triblock Copolymeric Micelles Decorated with a Cell-Penetrating Peptide Provide Efficient Doxorubicin Delivery
Khen Eng Ng (2016)
10.2174/1568026614666140329224716
PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
P. Hervella (2014)
Développement de deux plateformes pharmaceutiques gélifiées : un hydrogel de nanocapsules lipidiques et un organogel avec le même agent de réticulation
M. Pitorre (2017)
Physicochemical characterization of drug nanocarriers eloísa
Berbel Manaia (2017)
10.1016/j.micron.2012.07.008
Electron microscopy of pharmaceutical systems.
V. Klang (2013)
Supramolecular Polymeric Micelles Based on α-Cyclodextrin Derivative and Aliphatic Polycarbonates for Delivery of Doxorubicin
Jiaojiao Du (2014)
Development of micron and submicron scale carriers for drugs and nutrients delivery
Cholpon Rustem Kyzy (2018)
10.1016/j.ijpharm.2011.11.038
Optimisation of multiple W/O/W nanoemulsions for dermal delivery of aciclovir.
J. Schwarz (2012)
10.1201/B19038-64
Vegetable Oil-Based Formulations for Controlled Drug Delivery
V. K. Singh (2015)
10.1016/j.jconrel.2019.11.016
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market.
M. Gonçalves (2019)
10.1016/J.INDCROP.2015.08.057
Exploitation of amaranth oil fractions enriched in squalene for dual delivery of hydrophilic and lipophilic actives
C. Ott (2015)
10.1016/j.ijpharm.2016.02.019
Lipid-based nanoformulations for peptide delivery.
N. Matougui (2016)
10.1016/j.ijpharm.2018.09.034
Optimized acriflavine‐loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer
Y. Montigaud (2018)
10.1016/j.ijpharm.2020.119598
Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: formulation, in-vitro appraisal and pharmacokinetics.
Asmaa A Ashour (2020)
10.1039/C3SM51064F
Adhesive water-in-oil nano-emulsions generated by the phase inversion temperature method
N. Anton (2013)
10.2147/IJN.S147659
Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
T. Briot (2017)
10.1016/j.biomaterials.2014.02.022
The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
N. Mehra (2014)
10.1016/J.CEJ.2015.04.152
Doxorubicin-loaded magnetic nanocapsules based on N-palmitoyl chitosan and magnetite: Synthesis and characterization
V. Balan (2015)
10.1016/j.ejps.2013.06.013
Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
Benjamin Saliou (2013)
10.3390/nano10061185
Bioinspired Nanoemulsions Stabilized by Phosphoethanolamine and Phosphoglycerol Lipids
Carlo Caianiello (2020)
10.2174/2468187308666180307152049
Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges
A. Singh (2019)
10.3109/1061186X.2013.789033
Nanocarriers for oral drug delivery
Lin Zhang (2013)
10.2147/IJN.S180040
Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide
Anne-Claire Groo (2018)
10.1007/s12010-012-9641-8
Binding and Encapsulation of Doxorubicin on Smart Pectin Hydrogels for Oral Delivery
V. Bosio (2012)
10.1016/j.ijpharm.2012.06.026
Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride.
S. Vrignaud (2012)
Optimisation pharmacologique des dérivés de la créatine pour le traitement du déficit en transporteur de la créatine
Alexandra Trotier-Faurion (2013)
10.1515/bnm-2014-0009
Antibacterial polyamides based on a dendritic zinc-hybrid with good biocompatibility showing reduced biofilm formation
Michael Gladitz (2014)
10.1016/j.jconrel.2013.06.014
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging.
G. Bastiat (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar